Literature DB >> 18987813

GoldenGate assay for DNA methylation profiling.

Marina Bibikova1, Jian-Bing Fan.   

Abstract

We describe a highly reproducible and multiplexed method, the GoldenGate assay for methylation, for high-throughput quantitative measurements of DNA methylation. It can analyze up to 1,536 targeted CpG sites in 96 samples simultaneously, using only 250 ng of genomic DNA. The method is akin to a "genotyping" of bisulfite-converted DNA. Assay probes can be designed to interrogate the Watson strand, the Crick strand, or both strands at each CpG site. Assay end products are processed using Illumina universal bead arrays. As a result, gene or CpG sets can be refined iteratively--no custom arrays need to be developed. This method allows the detection of as little as 2.5% methylation, and can distinguish 17% difference in absolute methylation level between samples. The method is highly reproducible and compares very well with other common methods of methylation detection, such as methylation-specific PCR and bisulfite sequencing. The Illumina GoldenGate Methylation technology should prove useful for DNA methylation analyses in large populations, with potential application to biomarker discovery and validation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 18987813     DOI: 10.1007/978-1-59745-522-0_12

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  72 in total

1.  Methylation profiling identifies 2 groups of gliomas according to their tumorigenesis.

Authors:  Julien Laffaire; Sibille Everhard; Ahmed Idbaih; Emmanuelle Crinière; Yannick Marie; Aurelien de Reyniès; Renaud Schiappa; Karima Mokhtari; Khê Hoang-Xuan; Marc Sanson; Jean-Yves Delattre; Joëlle Thillet; François Ducray
Journal:  Neuro Oncol       Date:  2010-10-05       Impact factor: 12.300

2.  Aberrant silencing of cancer-related genes by CpG hypermethylation occurs independently of their spatial organization in the nucleus.

Authors:  Hariharan P Easwaran; Leander Van Neste; Leslie Cope; Subhojit Sen; Helai P Mohammad; Gayle J Pageau; Jeanne B Lawrence; James G Herman; Kornel E Schuebel; Stephen B Baylin
Journal:  Cancer Res       Date:  2010-08-24       Impact factor: 12.701

3.  Infant growth restriction is associated with distinct patterns of DNA methylation in human placentas.

Authors:  Carolyn E Banister; Devin C Koestler; Matthew A Maccani; James F Padbury; E Andres Houseman; Carmen J Marsit
Journal:  Epigenetics       Date:  2011-07       Impact factor: 4.528

4.  DNA methylation and gene expression differences in children conceived in vitro or in vivo.

Authors:  Sunita Katari; Nahid Turan; Marina Bibikova; Oluwatoyin Erinle; Raffi Chalian; Michael Foster; John P Gaughan; Christos Coutifaris; Carmen Sapienza
Journal:  Hum Mol Genet       Date:  2009-07-15       Impact factor: 6.150

Review 5.  Basic concepts of microarrays and potential applications in clinical microbiology.

Authors:  Melissa B Miller; Yi-Wei Tang
Journal:  Clin Microbiol Rev       Date:  2009-10       Impact factor: 26.132

Review 6.  Genome-scale approaches to the epigenetics of common human disease.

Authors:  Andrew P Feinberg
Journal:  Virchows Arch       Date:  2009-10-21       Impact factor: 4.064

Review 7.  Principles and challenges of genomewide DNA methylation analysis.

Authors:  Peter W Laird
Journal:  Nat Rev Genet       Date:  2010-03       Impact factor: 53.242

8.  Array-based DNA methylation profiling of primary lymphomas of the central nervous system.

Authors:  Julia Richter; Ole Ammerpohl; José I Martín-Subero; Manuel Montesinos-Rongen; Marina Bibikova; Eliza Wickham-Garcia; Otmar D Wiestler; Martina Deckert; Reiner Siebert
Journal:  BMC Cancer       Date:  2009-12-21       Impact factor: 4.430

9.  Analysis of the association between CIMP and BRAF in colorectal cancer by DNA methylation profiling.

Authors:  Toshinori Hinoue; Daniel J Weisenberger; Fei Pan; Mihaela Campan; Myungjin Kim; Joanne Young; Vicki L Whitehall; Barbara A Leggett; Peter W Laird
Journal:  PLoS One       Date:  2009-12-21       Impact factor: 3.240

10.  Polycomb CBX7 promotes initiation of heritable repression of genes frequently silenced with cancer-specific DNA hypermethylation.

Authors:  Helai P Mohammad; Yi Cai; Kelly M McGarvey; Hariharan Easwaran; Leander Van Neste; Joyce E Ohm; Heather M O'Hagan; Stephen B Baylin
Journal:  Cancer Res       Date:  2009-07-14       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.